# Buprenorphine and Naloxone

NDC: 67296-2228
Generic name: buprenorphine and naloxone
Labeler / Manufacturer: Redpharm Drug
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: FILM
Routes: BUCCAL, SUBLINGUAL
Marketing started: 20230829

FDA application: ANDA212756

## Active ingredients

- BUPRENORPHINE HYDROCHLORIDE: 2 mg/1
- NALOXONE HYDROCHLORIDE: .5 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"67296-2228"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=67296-2228
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5005a6c8-9a3b-a99a-e063-6294a90aac13